Neumora Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full management transaction log of Neumora Therapeutics, Inc., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €328.1m. The latest transaction was filed on 23 May 2025 (Don). Among the most active insiders: ARCH Venture Partners XII, LLC. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 23 May 2025
All Executives54 Thresholds0 Prospectus0 Other0
Declarations 54 total
● President · Executives · 21 May 2025
13,202 shares 0Common Stock SEC:0001610717-25-000128:0
▼ See Remarks · Executives · 18 Feb 2025
13,871 shares @ US$1.6919 100.0% of flow Common Stock SEC:0001610717-25-000031:0
▼ President · Executives · 18 Feb 2025
8,048 shares @ US$1.6746 2.7% of flow Common Stock SEC:0001610717-25-000027:0
▼ See Remarks · Executives · 18 Feb 2025
1,978 shares @ US$1.6939 100.0% of flow Common Stock SEC:0001610717-25-000030:0
▼ Chief Strategy Officer · Executives · 18 Feb 2025
8,565 shares @ US$1.6751 100.0% of flow Common Stock SEC:0001610717-25-000029:0
▼ Head of R&D · Executives · 18 Feb 2025
5,614 shares @ US$1.6714 1.2% of flow Common Stock SEC:0001610717-25-000028:0
● Director · Executives · 27 Dec 2024
133,097 shares 0Common Stock SEC:0001610717-24-000555:0
◇ Director · Executives · 17 Oct 2024
3,783 shares @ US$8.32 100.0% of flow Common Stock SEC:0001610717-24-000511:0
▼ Head of R&D · Executives · 9 Oct 2024
5,563 shares @ US$15.0112 10.1% of flow Common Stock SEC:0001610717-24-000505:0
▼ Head of R&D · Executives · 17 Sept 2024
30,788 shares @ US$11.8142 43.5% of flow Common Stock SEC:0001610717-24-000490:0
▼ Head of R&D · Executives · 12 Sept 2024
32,948 shares @ US$11.4321 45.2% of flow Common Stock SEC:0001610717-24-000478:0
▼ Chief Financial Officer · Executives · 27 Aug 2024
15,693 shares @ US$11.394 34.0% of flow Common Stock SEC:0001610717-24-000457:0
▼ Chief Financial Officer · Executives · 22 Aug 2024
28,496 shares @ US$11.6321 63.3% of flow Common Stock SEC:0001610717-24-000456:0
● Chief Financial Officer · Executives · 17 Apr 2024
238,965 shares 0Common Stock SEC:0001610717-24-000380:0
◆ Director · Executives · 13 Jun 2024
20,100 shares 0Common Stock SEC:0001610717-24-000338:0
◆ Director · Executives · 13 Jun 2024
20,100 shares 0Common Stock SEC:0001610717-24-000335:0
◆ Director · Executives · 13 Jun 2024
20,100 shares 0Common Stock SEC:0001610717-24-000334:0
◆ Director · Executives · 13 Jun 2024
20,100 shares 0Common Stock SEC:0001610717-24-000337:0
◆ Director · Executives · 13 Jun 2024
20,100 shares 0Common Stock SEC:0001610717-24-000336:0
● Chief Strategy Officer · Executives · 22 Apr 2024
114,703 shares 0Common Stock SEC:0001610717-24-000222:0
◆ Head of R&D · Executives · 14 Feb 2024
50,000 shares 0Common Stock SEC:0001610717-24-000063:0
◆ President & CEO · Executives · 14 Feb 2024
80,000 shares 0Common Stock SEC:0001610717-24-000065:0
◆ See Remarks · Executives · 14 Feb 2024
20,625 shares 0Common Stock SEC:0001610717-24-000064:0
◆ Chief Strategy Officer · Executives · 14 Feb 2024
97,500 shares 0Common Stock SEC:0001610717-24-000068:0
◆ Director · Executives · 14 Feb 2024
171,250 shares 0Common Stock SEC:0001610717-24-000066:0
25 of 54 declarations
Load more (29 remaining)